DNAC Social Capital Suvretta Holdings Corp. III - Class A
Social Capital Suvretta Holdings Corp. III focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on searching for a target business operating in the biotechnology industry and within the organ space sub-sector. The company was incorporated in 2021 and is based in Henderson, Nevada.
On 1/18/2022 the company announced a proposed merger with ProKidney LP, a leading clinical-stage cellular therapeutics company focused on chronic kidney disease.
$9.28 -0.72 (-7.20%)
As of 07/11/2022 16:00:00 EST IEX book CBOE book
Security Information
Category1: US Equity
Category2: Common stocks
Category3: Micro cap
GICS sector: Financials
Industry: Shell Companies
Index country: USA
Country of incorporation:
IPO date: 06/30/2021
Outstanding shares: 25,640,000
Average volume: 338,836
Market cap: $237,939,200
Current dividend yield: 0.00%
All SEC filings: SEC Edgar Online
Quarterly filings: 10-Q
Annual filings: 10-K
Sedol:
Valuation (See tab for details)
PE ratio: 0.00
PB ratio: 0.00
PS ratio: 0.00
Return on equity: 0.00%
Net income %: 0.00%